Contrast Agents And Radiopharmaceuticals – Market Insights – Europe
Because the COVID-19 pandemic is negatively affecting the overall volume of diagnostic imaging procedures, the pandemic will have a significant impact on the European contrast agent and radiopharmaceutical market in the short term. Once the situation improves, the European contrast agent and radiopharmaceutical market will resume slow growth through 2029, driven by rising radiopharmaceutical ASPs and increasing demand for diagnostic imaging procedures for Europe's aging population, although the market will be hindered to some extent by stringent reimbursement regulations and the ongoing safety controversy surrounding GBCAs.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in Europe across a 10-year period.
The COVID-19 pandemic will affect the contrast agent and radiopharmaceutical market.
To what extent will the COVID-19 pandemic impact the European contrast agent and radiopharmaceutical market?
How will the impact of the COVID-19 pandemic differ between segments?
How quickly are procedure volumes expected to rebound?
Recent studies have questioned the safety of GBCAs.
How has the EMA responded to studies that call into question the safety of GBCAs?
To what extent will these studies impact the MRI contrast agent market through 2029?
How can competitors best respond to these safety concerns such that the impact on their products and revenues can be minimized?
Global fluctuations in the supply of Mo-99—the key isotope in the production of Tc for use in most SPECT procedures—will continue to negatively impact the market going forward.
To what extent will supply limitations affect revenue growth in the European SPECT radiopharmaceutical market?
Less contrast material is being used per patient procedure in Europe.
What are some of the key factors driving this trend?
What novel technology will contribute to this trend in the future?
Which markets will be the most impacted by this shift in usage?
The European market is more competitive compared to the US market.
What are the key factors end users look for in a product?
How do local competitors fare compared to MNCs in the European contrast agent and radiopharmaceutical market?
How can smaller companies best position themselves to garner more market share going forward?
Table of contents
- Contrast Agents And Radiopharmaceuticals - Market Insights - Europe
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe
- Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2019u20132030
- Contrast Agent and Radiopharmaceutical Market Landscape, Europe (USD), 2020u00a0and 2030
- Competitive Highlights
- Competitive Factors and Strategies, by Product Type, Europe
- Contrast Agent and Radiopharmaceutical Procedure Market Share Rankings, by Product Type, Europe, 2020
- Companies Mentioned
- Market Developments
- Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
- Geographies Covered
- Geographies Covered, Europe
- Average Currency Exchange Rates
- Procedures and Products Covered
- Contrast Agent and Radiopharmaceutical Procedures and Products Covered, Europe
- COVID-19 Updates
- Key Report Updates
- COVID-19 Analysis
- Market Impact
- COVID-19 Impact Assessment Summary, Contrast Agent and Radiopharmaceutical Market, Europe
- Major Market Forecast Changes and Assumptions
- Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2019u20132030 (Excluding COVID-19 Impact)
- Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2019u20132030 (Including COVID-19 Impact)
- Competitive Impact
- COVID-19 Competitive Factors and Strategies, Contrast Agent and Radiopharmaceutical Market, Europe
- COVID-19 Financial Impact and Competitor Insights
- Market Impact
- Contrast Agent and Radiopharmaceutical Market
- Market Highlights
- Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe
- Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2019u20132030
- Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD), 2019u20132030
- Market Definitions
- Market Forecast Data
- Contrast Agent and Radiopharmaceutical Procedures, by Product Type, Europe, 2019u20132030
- Contrast Agent and Radiopharmaceutical Procedures, by Country, Europe, 2019u20132030
- Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD and EUR), 2019u20132030
- Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD, EUR, and GBP), 2019u20132030
- Competitive Highlights
- Market Shares
- Contrast Agent and Radiopharmaceutical Procedure Market Shares, Europe, 2020
- Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2020
- Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Product Type, Europe, 2020
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, Europe
- Market Developments
- Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
- Market Highlights
- Radiopharmaceutical Market
- Market Highlights
- Radiopharmaceutical Market, by Product Type, Europe (USD), 2019u20132030
- Radiopharmaceutical Market, by Country, Europe (USD), 2019u20132030
- Market Definitions
- Market Forecast Data
- Radiopharmaceutical Market, by Product Type, Europe (USDu200b), 2019u20132030
- Radiopharmaceutical Market, by Product Type, Europe (EUR), 2019u20132030
- Radiopharmaceutical Market Growth, by Product Type, Europe, 2020u20132030
- Radiopharmaceutical Market, by Country, Europe (USD), 2019u20132030
- Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2019u20132030
- Radiopharmaceutical Market Growth, by Country, Europe, 2020u20132030
- Nuclear Medicine System Installed Base, by Product Type, Europe, 2019u20132030
- Nuclear Medicine System Installed Base, by Country, Europe, 2019u20132030
- SPECT Radiopharmaceutical Market, by Country, Europe (USD), 2019u20132030
- SPECT Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2019u20132030
- SPECT Radiopharmaceutical Market Growth, by Country, Europe, 2020u20132030
- SPECT System Installed Base, by Country, Europe, 2019u20132030
- PET Radiopharmaceutical Market, by Country, Europe (USD), 2019u20132030
- PET Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2019u20132030
- PET Radiopharmaceutical Market Growth, by Country, Europe, 2020u20132030
- PET System Installed Base, by Country, Europe, 2019u20132030
- Competitive Highlights
- Market Shares
- SPECT Radiopharmaceutical Procedure Market Shares, Europe, 2020
- SPECT Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2020
- Competitive Factors and Strategies
- Competitive Factors and Strategies, Europe
- Market Highlights
- CT and X-Ray Contrast Agent Market
- Market Highlights
- CT and X-Ray Contrast Agent Market, by Product Type, Europe (USD), 2019u20132030
- CT and X-Ray Contrast Agent Market, by Country, Europe (USD), 2019u20132030
- Market Definitions
- Market Forecast Data
- CT and Xu2013Ray Contrast Agent Market, by Product Type, Europe (USD), 2019u20132030
- CT and Xu2013Ray Contrast Agent Market, by Product Type, Europe (EUR), 2019u20132030
- CT and X-Ray Contrast Agent Market Growth, by Product Type, Europe, 2020u20132030
- CT and Xu2013Ray Contrast Agent Market, by Country, Europe (USD), 2019u20132030
- CT and Xu2013Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2019u20132030
- CT and X-Ray Contrast Agent Market Growth, by Country, Europe, 2020u20132030
- CT and Xu2013Ray System Installed Base, by Country, Europe, 2019u20132030
- CT System Installed Base, by Country, Europe, 2019u20132030
- Xu2013Ray System Installed Base, by Country, Europe, 2019u20132030
- CT Contrast Agent Market, by Country, Europe (USD), 2019u20132030
- CT Contrast Agent Market, by Country, Europe (EUR and GBP), 2019u20132030
- CT Contrast Agent Market Growth, by Country, Europe, 2020u20132030
- Cardiovascular Xu2013Ray Contrast Agent Market, by Country, Europe (USDu200b), 2019u20132030
- Cardiovascular Xu2013Ray Contrast Agent Market, by Country, Europe (EURu200b and GBP), 2019u20132030
- Cardiovascular Xu2013Ray Contrast Agent Market Growth, by Country, Europe, 2020u20132030
- Conventional Xu2013Ray Contrast Agent Market, by Country, Europe (USDu200b), 2019u20132030
- Conventional Xu2013Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2019u20132030
- Conventional Xu2013Ray Contrast Agent Market Growth, by Country, Europe, 2020u20132030
- Competitive Highlights
- Market Shares
- CT and Xu2013Ray Contrast Agent Procedure Market Shares, Europe, 2020
- CT and Xu2013Ray Contrast Agent Procedure Market Shares, by Country, Europe, 2020
- Competitive Factors and Strategies
- Competitive Factors and Strategies, Europe
- Market Highlights
- MRI Contrast Agent Market
- Market Highlights
- MRI Contrast Agent Market, by Country, Europe (USD), 2019u20132030
- Market Definitions
- Market Forecast Data
- MRI Contrast Agent Market, by Country, Europe (USD), 2019u20132030
- MRI Contrast Agent Market, by Country, Europe (EUR and GBP), 2019u20132030
- MRI Contrast Agent Market Growth, by Country, Europe, 2020u20132030
- MRI System Installed Base, by Country, Europe, 2019u20132030
- Competitive Highlights
- Market Shares
- MRI Contrast Agent Procedure Market Shares, Europe, 2020
- MRI Contrast Agent Procedure Market Shares, by Country, Europe, 2020
- Competitive Factors and Strategies
- Competitive Factors and Strategies, Europe
- Market Highlights
- Ultrasound Contrast Agent Market
- Market Highlights
- Ultrasound Contrast Agent Market, by Country, Europe (USD), 2019u20132030
- Market Definitions
- Market Forecast Data
- Ultrasound Contrast Agent Market, by Country, Europe (USDu200b), 2019u20132030
- Ultrasound Contrast Agent Market, by Country, Europe (EUR and GBP), 2019u20132030
- Ultrasound Contrast Agent Market Growth, by Country, Europe, 2020u20132030
- Competitive Highlights
- Market Share Rankings
- Ultrasound Contrast Agent Procedure Market Share Rankings, Europe, 2020
- Competitive Factors and Strategies
- Competitive Factors and Strategies, Europe
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Vijjapu Kameswara Rao is a research associate on the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in the gynecological device market. Kamesh holds a Bachelor’s degree in Pharmaceutical Sciences from the Jawaharlal Nehru Technological University Kakinada and a Master’s degree in Pharmaceutical Analysis from the National Institute of Pharmaceutical Education and Research, Mohali.